Stay updated on Comparing Lenvatinib vs Sorafenib in Hepatocellular Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Comparing Lenvatinib vs Sorafenib in Hepatocellular Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Comparing Lenvatinib vs Sorafenib in Hepatocellular Carcinoma Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    A site-wide NIH banner announces that agencies are using “Super Intelligence” in place of “Artificial Intelligence” during a transition. It appears above the clinical-trial page, which displays a 403 error.
    Difference
    1%
    Check dated 2026-10-26T14:13:20.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov error page footer now displays revision v3.7.2 instead of v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-19T14:09:54.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.0 to v3.7.1; the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-12T14:42:52.000Z thumbnail image
  4. Check
    37 days ago
    Change Detected
    Summary
    The study page now renders a 403 Forbidden error, blocking access to the NCT01761266 details. The page displays an error message and site chrome instead of the trial information.
    Difference
    18%
    Check dated 2026-09-21T22:01:31.000Z thumbnail image
  5. Check
    58 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.5 to v3.6.6, indicating a minor metadata update without substantive changes to the study information.
    Difference
    0.0%
    Check dated 2026-08-31T16:16:13.000Z thumbnail image
  6. Check
    79 days ago
    Change Detected
    Summary
    The page's revision identifier was updated from v3.6.4 to v3.6.5, indicating an updated internal version of the study record. It does not reflect changes to the study data or how users interact with the page.
    Difference
    0.0%
    Check dated 2026-08-10T15:25:00.000Z thumbnail image

Stay in the know with updates to Comparing Lenvatinib vs Sorafenib in Hepatocellular Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Comparing Lenvatinib vs Sorafenib in Hepatocellular Carcinoma Clinical Trial page.